About
Contact & Profiles
A5092932680
Research Areas
- Sinusitis and nasal conditions
- Ear and Head Tumors
- Salivary Gland Tumors Diagnosis and Treatment
- Viral-associated cancers and disorders
- Respiratory and Cough-Related Research
- Pediatric health and respiratory diseases
Péterfy Sándor Utcai Kórház-Rendelőintézet és Baleseti Központ
2023-2024
Background: Research on the immune mechanism behind chronic rhinosinusitis (CRS) has revealed various new endotypes, leading to targeted therapies, especially for severe uncontrolled CRS. Biologics are novel therapeutic strategies providing treatment difficult-to-treat recalcitrant CRSwNP patients. Dupilumab is a fully human-derived monoclonal antibody that binds IL4Rα, inhibiting signalling of both IL-4 and IL-13. In Hungary, it approved according criteria based EPOS2020 Hungarian...
10.4193/rhin23.278
article
EN
Rhinology Journal
2024-06-01
Coming Soon ...